Evaluation of a novel, multicomponent anxiety management programme for people with intellectual disability: protocol for a mixed-methods, quasi-experimental feasibility study

Jones, StevenActon, DannyJaydeokar, SujeetLane, StevenWoodrow, CeriTalbot, GraceWilliams, Jonathan2023-09-222023-09-222023-09-20Acton, D., Williams, J., Woodrow, C., Talbot, G., Jones, S., Lane, S., & Jaydeokar, S. (2023). Evaluation of a novel, multicomponent anxiety management programme for people with intellectual disability: Protocol for a mixed-methods, quasi-experimental feasibility study. BMJ Open, 13(9), article-number e078411. https://doi.org/10.1136/bmjopen-2023-07841110.1136/bmjopen-2023-078411http://hdl.handle.net/10034/628088Studies have shown some benefits to single approaches to psychological therapies for the treatment of anxiety in people with intellectual disability such as modified cognitive–behavioural therapy and mindfulness. To our knowledge, no studies have used a multicomponent approach for the individual treatment of anxiety-related disorders in this population group. A co-production group of clinical experts and people with intellectual disability has created a novel multicomponent anxiety management programme (MCAMP-ID). The aims of this study are to investigate (1) the feasibility of this approach in reducing anxiety for people with a mild/moderate intellectual disability, (2) the feasibility of outcome measures and (3) the feasibility of completing a future randomised controlled trial of this programme. The data from this feasibility study will be used to inform trial design and to complete power calculation.CC0 1.0 Universalhttps://creativecommons.org/licenses/by-nc/4.0/quasi-experimental feasibility studyintellectual disabilityEvaluation of a novel, multicomponent anxiety management programme for people with intellectual disability: protocol for a mixed-methods, quasi-experimental feasibility studyArticle2044-6055BMJ Open